WFDC5 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the WFDC5 protein, which belongs to the whey acidic protein (WAP) domain family. The WFDC5 protein contains the characteristic WAP domain, a conserved structure known for its role in the regulation of protease activity, particularly serine proteases. Serine proteases are involved in various biological processes such as immune responses, tissue remodeling, and cellular signaling. WFDC5, like other members of the WAP family, is thought to function as a protease inhibitor, playing a key role in controlling proteolytic activity within different physiological contexts. Inhibiting WFDC5 impacts its ability to regulate protease interactions, potentially altering pathways involved in maintaining cellular homeostasis and structural integrity.
The molecular mechanism of WFDC5 inhibitors typically involves the binding of the inhibitor to the WAP domain or other critical regions of the WFDC5 protein, thereby preventing it from interacting with and inhibiting specific target proteases. This disruption leads to changes in protease activity, affecting processes such as extracellular matrix degradation, immune cell function, and tissue organization. Researchers utilize WFDC5 inhibitors to study the specific role of this protein in protease regulation and to investigate its broader influence on cellular and molecular systems. By selectively inhibiting WFDC5, these compounds offer valuable insights into the complex regulatory networks of proteolysis, allowing scientists to better understand the biological importance of WAP domain-containing proteins in maintaining protease balance and their involvement in various cellular functions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor, impacting various cellular processes that might intersect with WFDC5's function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A phosphoinositide 3-kinases (PI3K) inhibitor, potentially altering cellular signaling pathways affecting WFDC5. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
A MEK inhibitor, potentially affecting the ERK/MAPK pathway, which could indirectly influence WFDC5 activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAP kinase, possibly altering signaling pathways relevant to WFDC5's function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor, potentially modifying signaling pathways indirectly affecting WFDC5. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Inhibits V-ATPase, potentially impacting endosomal-lysosomal functioning, influencing WFDC5 indirectly. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Known to affect autophagy and lysosomal function, which might indirectly influence WFDC5. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $56.00 $256.00 | 113 | |
An autophagy inhibitor, potentially impacting WFDC5 indirectly. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A potent PI3K inhibitor, potentially affecting WFDC5 activity through intracellular signaling pathways. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
A ROCK inhibitor, potentially influencing cytoskeletal dynamics relevant to WFDC5's function. | ||||||